Notch Signaling Suppression by Golden Phytochemicals: Potential for Cancer Therapy

Area of Science:

• Oncology
• Pharmacology
• Molecular Biology

Background:

• Cancer is a leading global cause of mortality, driven by unregulated cellular processes like proliferation and angiogenesis.
• Dysregulated signaling pathways, including NF-κB, Wnt/beta-catenin, Notch, and MAPK, are implicated in cancer progression.
• Notch signaling is a critical pathway involved in the advancement of various malignant tumors.

Purpose of the Study:

• To review the current status, impact, and potential of phytochemicals as cancer therapeutics.
• To focus on the role of phytochemicals in targeting key signaling pathways, with a specific emphasis on the Notch pathway.
• To explore natural compounds as potential alternatives to synthetic chemotherapeutics due to their pleiotropic effects and reduced toxicity.

Main Methods:

• Literature review of existing research on phytochemicals and cancer signaling pathways.
• Analysis of the mechanisms by which phytochemicals interact with key cancer-related signaling pathways.
• Focus on compounds such as curcumin, genistein, quercetin, silibinin, resveratrol, cucurbitacin, and glycyrrhizin.

Main Results:

• Phytochemicals exhibit pleiotropic effects, simultaneously targeting multiple signaling pathways crucial for cancer growth.
• Certain natural compounds show significant potential in modulating the Notch signaling pathway.
• Natural products offer a promising avenue for developing safer and more effective cancer therapies.

Conclusions:

• Natural products, or phytochemicals, represent a valuable resource for novel cancer therapies.
• Targeting key signaling pathways, particularly Notch, with phytochemicals can overcome tumor heterogeneity and reduce synthetic drug side effects.
• This review highlights the potential of 'golden phytochemicals' for developing next-generation, natural chemotherapeutics.